146 related articles for article (PubMed ID: 9616518)
21. Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome.
Quinn RA; Adem S; Mills RH; Comstock W; DeRight Goldasich L; Humphrey G; Aksenov AA; Melnik AV; da Silva R; Ackermann G; Bandeira N; Gonzalez DJ; Conrad D; O'Donoghue AJ; Knight R; Dorrestein PC
Microbiome; 2019 Feb; 7(1):23. PubMed ID: 30760325
[TBL] [Abstract][Full Text] [Related]
22. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.
Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE
J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881
[TBL] [Abstract][Full Text] [Related]
23. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.
Bruce MC; Poncz L; Klinger JD; Stern RC; Tomashefski JF; Dearborn DG
Am Rev Respir Dis; 1985 Sep; 132(3):529-35. PubMed ID: 3898942
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors.
Schuster A; Fahy JV; Ueki I; Nadel JA
Eur Respir J; 1995 Jan; 8(1):10-4. PubMed ID: 7744174
[TBL] [Abstract][Full Text] [Related]
26. The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.
Jovic S; Linge HM; Shikhagaie MM; Olin AI; Lannefors L; Erjefält JS; Mörgelin M; Egesten A
Mucosal Immunol; 2016 Jan; 9(1):112-23. PubMed ID: 25993443
[TBL] [Abstract][Full Text] [Related]
27. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
28. Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis.
Prandini P; De Logu F; Fusi C; Provezza L; Nassini R; Montagner G; Materazzi S; Munari S; Gilioli E; Bezzerri V; Finotti A; Lampronti I; Tamanini A; Dechecchi MC; Lippi G; Ribeiro CM; Rimessi A; Pinton P; Gambari R; Geppetti P; Cabrini G
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):645-656. PubMed ID: 27281024
[TBL] [Abstract][Full Text] [Related]
29. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
Konstan MW; Hilliard KA; Norvell TM; Berger M
Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
31. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of neutrophil elastase in CF sputum by L-658,758.
Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
34. Host response to Pseudomonas aeruginosa.
Döring G
Acta Paediatr Scand Suppl; 1989; 363():37-9; discussion 40. PubMed ID: 2518396
[TBL] [Abstract][Full Text] [Related]
35. Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa.
Jovic S; Shikhagaie M; Mörgelin M; Kjellström S; Erjefalt J; Olin AI; Frick IM; Egesten A
J Innate Immun; 2014; 6(6):846-59. PubMed ID: 25115612
[TBL] [Abstract][Full Text] [Related]
36. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
37. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
38. Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Jagger KS; Bahner DR; Warren RL
J Clin Microbiol; 1983 Jan; 17(1):55-9. PubMed ID: 6402520
[TBL] [Abstract][Full Text] [Related]
39. Proteases and cystic fibrosis.
Voynow JA; Fischer BM; Zheng S
Int J Biochem Cell Biol; 2008; 40(6-7):1238-45. PubMed ID: 18395488
[TBL] [Abstract][Full Text] [Related]
40. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
